BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 18195012)

  • 1. BIM and tBID are not mechanistically equivalent when assisting BAX to permeabilize bilayer membranes.
    Terrones O; Etxebarria A; Landajuela A; Landeta O; Antonsson B; Basañez G
    J Biol Chem; 2008 Mar; 283(12):7790-803. PubMed ID: 18195012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct lipid effects on tBid and Bim activation of membrane permeabilization by pro-apoptotic Bax.
    Shamas-Din A; Bindner S; Chi X; Leber B; Andrews DW; Fradin C
    Biochem J; 2015 May; 467(3):495-505. PubMed ID: 25714678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BH3 domains other than Bim and Bid can directly activate Bax/Bak.
    Du H; Wolf J; Schafer B; Moldoveanu T; Chipuk JE; Kuwana T
    J Biol Chem; 2011 Jan; 286(1):491-501. PubMed ID: 21041309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.
    Kazi A; Sun J; Doi K; Sung SS; Takahashi Y; Yin H; Rodriguez JM; Becerril J; Berndt N; Hamilton AD; Wang HG; Sebti SM
    J Biol Chem; 2011 Mar; 286(11):9382-92. PubMed ID: 21148306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.
    Kuwana T; Bouchier-Hayes L; Chipuk JE; Bonzon C; Sullivan BA; Green DR; Newmeyer DD
    Mol Cell; 2005 Feb; 17(4):525-35. PubMed ID: 15721256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipidic pore formation by the concerted action of proapoptotic BAX and tBID.
    Terrones O; Antonsson B; Yamaguchi H; Wang HG; Liu J; Lee RM; Herrmann A; Basañez G
    J Biol Chem; 2004 Jul; 279(29):30081-91. PubMed ID: 15138279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A membrane-targeted BID BCL-2 homology 3 peptide is sufficient for high potency activation of BAX in vitro.
    Oh KJ; Barbuto S; Pitter K; Morash J; Walensky LD; Korsmeyer SJ
    J Biol Chem; 2006 Dec; 281(48):36999-7008. PubMed ID: 16987815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53.
    Zhang J; Huang K; O'Neill KL; Pang X; Luo X
    Cell Death Dis; 2016 Jun; 7(6):e2266. PubMed ID: 27310874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal Permeabilization Assay to Study the Functional Interactions of the BCL-2 Family.
    Reyna DE; Gavathiotis E
    Methods Mol Biol; 2019; 1877():111-119. PubMed ID: 30536001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Bcl-2 homology domain 3 (BH3)-only proteins Bim and bid are functionally active and restrained by anti-apoptotic Bcl-2 family proteins in healthy liver.
    Kodama T; Hikita H; Kawaguchi T; Saito Y; Tanaka S; Shigekawa M; Shimizu S; Li W; Miyagi T; Kanto T; Hiramatsu N; Tatsumi T; Takehara T
    J Biol Chem; 2013 Oct; 288(42):30009-30018. PubMed ID: 23986435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies.
    Kim H; Rafiuddin-Shah M; Tu HC; Jeffers JR; Zambetti GP; Hsieh JJ; Cheng EH
    Nat Cell Biol; 2006 Dec; 8(12):1348-58. PubMed ID: 17115033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell lymphoma-2 (BCL-2) homology domain 3 (BH3) mimetics demonstrate differential activities dependent upon the functional repertoire of pro- and anti-apoptotic BCL-2 family proteins.
    Renault TT; Elkholi R; Bharti A; Chipuk JE
    J Biol Chem; 2014 Sep; 289(38):26481-26491. PubMed ID: 25096574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax.
    Lovell JF; Billen LP; Bindner S; Shamas-Din A; Fradin C; Leber B; Andrews DW
    Cell; 2008 Dec; 135(6):1074-84. PubMed ID: 19062087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bax activation by Bim?
    Czabotar PE; Colman PM; Huang DC
    Cell Death Differ; 2009 Sep; 16(9):1187-91. PubMed ID: 19557009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAX insertion, oligomerization, and outer membrane permeabilization in brain mitochondria: role of permeability transition and SH-redox regulation.
    Brustovetsky T; Li T; Yang Y; Zhang JT; Antonsson B; Brustovetsky N
    Biochim Biophys Acta; 2010 Nov; 1797(11):1795-806. PubMed ID: 20655869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An interconnected hierarchical model of cell death regulation by the BCL-2 family.
    Chen HC; Kanai M; Inoue-Yamauchi A; Tu HC; Huang Y; Ren D; Kim H; Takeda S; Reyna DE; Chan PM; Ganesan YT; Liao CP; Gavathiotis E; Hsieh JJ; Cheng EH
    Nat Cell Biol; 2015 Oct; 17(10):1270-81. PubMed ID: 26344567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis.
    Kim H; Tu HC; Ren D; Takeuchi O; Jeffers JR; Zambetti GP; Hsieh JJ; Cheng EH
    Mol Cell; 2009 Nov; 36(3):487-99. PubMed ID: 19917256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization.
    Yamaguchi R; Lartigue L; Perkins G; Scott RT; Dixit A; Kushnareva Y; Kuwana T; Ellisman MH; Newmeyer DD
    Mol Cell; 2008 Aug; 31(4):557-569. PubMed ID: 18691924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of proapoptotic BAK function in liposomes reveals a dual role for mitochondrial lipids in the BAK-driven membrane permeabilization process.
    Landeta O; Landajuela A; Gil D; Taneva S; DiPrimo C; Sot B; Valle M; Frolov VA; Basañez G
    J Biol Chem; 2011 Mar; 286(10):8213-8230. PubMed ID: 21196599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obatoclax is a direct and potent antagonist of membrane-restricted Mcl-1 and is synthetic lethal with treatment that induces Bim.
    Nguyen M; Cencic R; Ertel F; Bernier C; Pelletier J; Roulston A; Silvius JR; Shore GC
    BMC Cancer; 2015 Aug; 15():568. PubMed ID: 26231047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.